PURA - Puration Begins To Outgrow Production Capacity And Plans Bottling Plant Expansion
March 12 2019 - 8:57AM
InvestorsHub NewsWire
PURA - Puration Begins To Outgrow
Production Capacity And Plans Bottling Plant Expansion
Dallas, TX -- March 12, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) (“PURA”) today announced that the expanding demand for
its EVERx CBD Sports Water is pushing the limits of its current
bottling production capacity. “Having our orders for EVERx CBD
Sports Water begin to overwhelm our bottling production capacity is
an exciting problem,” said Brian Shibley, CEO of Puration. “While
we are delighted to have great demand for EVERx, the risk of
getting behind on production is nonetheless still a problem, no
matter how exciting. We have some online customers already
frustrated with slow delivery and that’s not good. We
certainly don’t want to get behind with our wholesale buyers and we
need to go above and beyond to make it up to our online
buyers.” PURA recently announced beginning
discussions with its current bottler about the possibility of PURA
acquiring the bottler. The proposal to acquire the current
bottler includes investment plans to expand the current bottler’s
production capacity. “As we continue to innovate new
beverages, a key bottling partner or in-house capacity its
essential,” explained Mr. Shibley. PURA is also exploring
independent bottling capacity acquisitions in addition to
considering building out an all new plant. Management
anticipates finalizing expansion plans by the end of this month.
“Be it an acquisition or a new build out, the plan will be
finalized this month and we will proceed quickly to expand
production capacity one way or
another.”
Analyst Speculative Buy Recommendation and
$0.25 PPS Target with $0.35
Upside
Goldman Small Cap Research issued a
research update on Puration, Inc. (USOTC:
PURA) last week recommending a 'speculative-buy' rating with a target
price-per-share of $0.25, with noted potential upside to the
$0.35 mark.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024